跳至主要内容
临床试验/ISRCTN10362331
ISRCTN10362331进行中(未招募)未知

Cognitive Remediation in Bipolar (CRiB2): a randomised trial assessing efficacy and mechanisms of cognitive remediation therapy compared with usual care

King's College London0 个研究点目标入组 250 人开始时间: 2021年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
250

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37968619/ (added 16/11/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Have a confirmed diagnosis of bipolar disorder type I or II.
  • 2. Be aged between 18 and 65 years.
  • 3. Be euthymic (not in a mood episode) for at least 1 month.
  • 4. Be able to use a computerised device (e.g., computer / smartphone).

排除标准

  • Current participant exclusion criteria as of 04/05/2022:
  • 1. Substance use diagnosis (abuse or dependence).
  • 2. Risk of suicide.
  • 3. Impairing neurological disorder or MCI.
  • 4. Previous cognitive remediation therapy.
  • 5. Unable to communicate fluently in English.
  • 6. Intellectual disability.
  • 7. Currently undergoing psychological therapy or planning imminent treatment change.
  • 8. Non-provision of UK healthcare professional contact.
  • 9. Unable to travel to one of the research sites on a regular basis over 25 weeks.
  • 10. Unable to provide informed consent to participate.
  • Previous participant exclusion criteria:
  • 1. Substance use diagnosis (abuse or dependence).
  • 2. Risk of suicide.
  • 3. Impairing neurological disorder or MCI.
  • 4. Previous cognitive remediation therapy.
  • 5. Unable to communicate fluently in English.
  • 6. Intellectual disability.
  • 7. Currently undergoing psychological therapy or planning imminent treatment change.
  • 8. Non-provision of UK healthcare professional contact.
  • 9. Unable to provide informed consent to participate.

研究者

相似试验